Stay updated with breaking news from Nick Fox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
US drugmaker Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts.
'Remarkable' Alzheimer's drug reduces cognitive decline, study shows
US drugmaker Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline.
Trial of nearly 1,200 people with early forms of the disease
In a placebo controlled trial of nearly 1,200 people with early forms of the disease, donanemab slowed the progression of symptoms by 35% over a period of 18 months.